High Endogenous CCL2 Expression Promotes the Aggressive Phenotype of Human Inflammatory Breast Cancer

Researchers described a human inflammatory breast cancer (IBC) cell line, A3250, that recapitulated key IBC features in a mouse xenograft model, including skin erythema, diffuse tumor growth, dermal lymphatic invasion, and extensive metastases.